You are here

Shareholder Services: Pfizer Stock Information and Services for Shareholders

Direct Stock Purchase and Dividend Reinvestment Plan

Pfizer has authorized Computershare Trust Company, N.A. ("Computershare") to sponsor the Computershare CIP ("CIP"), a direct stock purchase and dividend reinvestment plan for Pfizer common stock. The CIP is offered and administered solely by Computershare, not by Pfizer, and replaces Pfizer's current Shareholder Investment Program ("SIP"). Current participants in the SIP will be automatically enrolled in the new CIP. You can learn more about the CIP for shareholders by contacting the plan administrator, Computershare. Please see details below.

P.O. BOX 30170
College Station, TX 77842-3170

Be sure to include your name, address, daytime phone number, account number, company name (as shown on your statement) on all correspondence.

+1-800-PFE-9393 (+1-800-733-9393) (U.S. and Canada)
+1-781-575-4591. (Outside U.S. and Canada)


Book-Entry Stock Ownership

  • The book-entry form of registered ownership allows you to own shares without having paper stock certificates in your possession.
  • You may open and maintain a book-entry account with us through our Transfer Agent, Computershare.
  • You may request stock certificates for the whole shares in your book-entry account at any time.

Direct Deposit of Pfizer Dividends

As a Pfizer shareholder of record (if your shares of Pfizer common stock are held in your own name), you have the option of depositing your dividends electronically into your bank account on each dividend payment date.

With direct deposit, your dividend funds are available to you on the dividend payment date. Instead of a check, you will receive a dividend payment statement from Pfizer. This statement will advise you of:

  • dividend amount deposited,
  • where it was deposited,
  • the date of deposit, and
  • the amount of tax, if any, that was withheld.


Stock Quote Disclaimer

20 minute delayed data provided by Comstock. Charts are provided by BigCharts and MarketWatch, Inc. Pfizer makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Note: Historical and current stock price performance data is not necessarily indicative of future performance.


If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. This link is provided as a convenience. Pfizer is not responsible for the content of this linked page.